Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · IEX Real-Time Price · USD
0.945
+0.025 (2.73%)
May 3, 2024, 1:03 PM EDT - Market open
Accelerate Diagnostics Revenue
In the year 2023, Accelerate Diagnostics had annual revenue of $12.06M, a decrease of -5.43%. Revenue in the quarter ending December 31, 2023 was $3.03M with 1.85% year-over-year growth.
Revenue (ttm)
$12.06M
Revenue Growth
-5.43%
P/S Ratio
1.69
Revenue / Employee
$89,993
Employees
134
Market Cap
20.36M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | 9.30M | 3.63M | 63.97% |
Dec 31, 2018 | 5.67M | 1.49M | 35.74% |
Dec 31, 2017 | 4.18M | 3.93M | 1,597.97% |
Dec 31, 2016 | 246.00K | 99.00K | 67.35% |
Dec 31, 2015 | 147.00K | 25.00K | 20.49% |
Dec 31, 2014 | 122.00K | 74.00K | 154.17% |
Dec 31, 2013 | 48.00K | -188.00K | -79.66% |
Jul 31, 2012 | 236.00K | -885.17K | -78.95% |
Jul 31, 2011 | 1.12M | -1.12M | -50.07% |
Jul 31, 2010 | 2.25M | 975.74K | 76.84% |
Jul 31, 2009 | 1.27M | 794.37K | 167.05% |
Jul 31, 2008 | 475.52K | 292.39K | 159.66% |
Jul 31, 2007 | 183.13K | -29.57K | -13.90% |
Jul 31, 2006 | 212.70K | -289.41K | -57.64% |
Jul 31, 2005 | 502.11K | 383.50K | 323.31% |
Jul 31, 2004 | 118.61K | 65.82K | 124.67% |
Jul 31, 2003 | 52.79K | -601.18K | -91.93% |
Jul 31, 2002 | 653.98K | -201.68K | -23.57% |
Jul 31, 2001 | 855.66K | -711.73K | -45.41% |
Jul 31, 2000 | 1.57M | -1.33M | -45.91% |
Jul 31, 1999 | 2.90M | -4.48M | -60.74% |
Jul 31, 1998 | 7.38M | 4.89M | 196.64% |
Jul 31, 1997 | 2.49M | 391.36K | 18.66% |
Jul 31, 1996 | 2.10M | 714.48K | 51.68% |
Jul 31, 1995 | 1.38M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
MEI Pharma | 72.65M |
Cumberland Pharmaceuticals | 39.55M |
American Shared Hospital Services | 21.33M |
Akso Health Group | 2.20M |
AIM ImmunoTech | 202.00K |
Benitec Biopharma | 61.00K |
Alaunos Therapeutics | 5.00K |
AXDX News
- 1 day ago - Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. - PRNewsWire
- 5 weeks ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results - PRNewsWire
- 2 months ago - Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. - PRNewsWire
- 3 months ago - Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement - PRNewsWire
- 3 months ago - Accelerate Diagnostics Announces Launch of Proposed Public Offering - PRNewsWire
- 4 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® - PRNewsWire
- 6 months ago - Accelerate Diagnostics Reports Third Quarter 2023 Results - PRNewsWire